Rank | Gene Set | Z-score |
---|---|---|
1 | drug transmembrane transport (GO:0006855) | 9.63397329 |
2 | urate metabolic process (GO:0046415) | 9.38735090 |
3 | aminoglycoside antibiotic metabolic process (GO:0030647) | 8.61090613 |
4 | drug transport (GO:0015893) | 8.43104097 |
5 | lysine catabolic process (GO:0006554) | 7.95942065 |
6 | lysine metabolic process (GO:0006553) | 7.95942065 |
7 | organic cation transport (GO:0015695) | 7.76128517 |
8 | phosphate ion transport (GO:0006817) | 7.02681980 |
9 | drug catabolic process (GO:0042737) | 6.77534730 |
10 | exogenous drug catabolic process (GO:0042738) | 6.23387575 |
11 | quaternary ammonium group transport (GO:0015697) | 6.12572177 |
12 | glyoxylate metabolic process (GO:0046487) | 6.03561103 |
13 | phosphate ion transmembrane transport (GO:0035435) | 5.86805629 |
14 | aspartate family amino acid catabolic process (GO:0009068) | 5.73833142 |
15 | response to mercury ion (GO:0046689) | 5.51418725 |
16 | tricarboxylic acid metabolic process (GO:0072350) | 5.51226437 |
17 | branched-chain amino acid metabolic process (GO:0009081) | 5.50224398 |
18 | renal absorption (GO:0070293) | 5.46242736 |
19 | modified amino acid transport (GO:0072337) | 5.44590235 |
20 | excretion (GO:0007588) | 5.31715303 |
21 | valine metabolic process (GO:0006573) | 5.31174673 |
22 | short-chain fatty acid metabolic process (GO:0046459) | 5.17428501 |
23 | homocysteine metabolic process (GO:0050667) | 5.17063736 |
24 | proline metabolic process (GO:0006560) | 5.07719680 |
25 | toxin transport (GO:1901998) | 4.97675423 |
26 | vitamin D metabolic process (GO:0042359) | 4.79205952 |
27 | intestinal cholesterol absorption (GO:0030299) | 4.73168077 |
28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.70131624 |
29 | branched-chain amino acid catabolic process (GO:0009083) | 4.67952554 |
30 | serine family amino acid catabolic process (GO:0009071) | 4.63792041 |
31 | oligosaccharide catabolic process (GO:0009313) | 4.63754553 |
32 | phosphate ion homeostasis (GO:0055062) | 4.62340057 |
33 | trivalent inorganic anion homeostasis (GO:0072506) | 4.62340057 |
34 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.59205640 |
35 | L-phenylalanine metabolic process (GO:0006558) | 4.59205640 |
36 | amino-acid betaine transport (GO:0015838) | 4.48334092 |
37 | carnitine transport (GO:0015879) | 4.48334092 |
38 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.47316693 |
39 | L-phenylalanine catabolic process (GO:0006559) | 4.47316693 |
40 | 2-oxoglutarate metabolic process (GO:0006103) | 4.45205717 |
41 | fructose metabolic process (GO:0006000) | 4.43975122 |
42 | intestinal absorption (GO:0050892) | 4.41871906 |
43 | NADH metabolic process (GO:0006734) | 4.38524879 |
44 | cobalamin metabolic process (GO:0009235) | 4.31376928 |
45 | metanephric tubule development (GO:0072170) | 4.29853042 |
46 | metanephric nephron tubule development (GO:0072234) | 4.29853042 |
47 | aromatic amino acid family catabolic process (GO:0009074) | 4.29742130 |
48 | * cysteine metabolic process (GO:0006534) | 4.21844172 |
49 | response to phenylpropanoid (GO:0080184) | 4.18031000 |
50 | amino-acid betaine metabolic process (GO:0006577) | 4.17162904 |
51 | plasma lipoprotein particle assembly (GO:0034377) | 4.15081459 |
52 | indole-containing compound catabolic process (GO:0042436) | 4.15050752 |
53 | indolalkylamine catabolic process (GO:0046218) | 4.15050752 |
54 | tryptophan catabolic process (GO:0006569) | 4.15050752 |
55 | glycoside metabolic process (GO:0016137) | 4.14717755 |
56 | fatty acid beta-oxidation (GO:0006635) | 4.12166962 |
57 | digestion (GO:0007586) | 4.08092703 |
58 | * leukotriene metabolic process (GO:0006691) | 4.01109923 |
59 | * nonribosomal peptide biosynthetic process (GO:0019184) | 4.00102254 |
60 | tryptophan metabolic process (GO:0006568) | 3.99821666 |
61 | * serine family amino acid metabolic process (GO:0009069) | 3.99085532 |
62 | beta-amyloid metabolic process (GO:0050435) | 3.95491121 |
63 | sulfur amino acid catabolic process (GO:0000098) | 3.93907427 |
64 | metanephric nephron epithelium development (GO:0072243) | 3.93742166 |
65 | vitamin transport (GO:0051180) | 3.90222346 |
66 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.89762662 |
67 | fatty acid oxidation (GO:0019395) | 3.82259427 |
68 | regulation of cholesterol esterification (GO:0010872) | 3.81896000 |
69 | sulfur compound transport (GO:0072348) | 3.74779711 |
70 | lipid oxidation (GO:0034440) | 3.74322384 |
71 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.73917467 |
72 | * leukotriene biosynthetic process (GO:0019370) | 3.73327268 |
73 | protein-lipid complex assembly (GO:0065005) | 3.73171845 |
74 | carnitine metabolic process (GO:0009437) | 3.66805718 |
75 | acetyl-CoA metabolic process (GO:0006084) | 3.66572097 |
76 | phospholipid efflux (GO:0033700) | 3.65348529 |
77 | fatty acid catabolic process (GO:0009062) | 3.63069338 |
78 | flavonoid metabolic process (GO:0009812) | 3.60906682 |
79 | polyol transport (GO:0015791) | 3.59187659 |
80 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.59030184 |
81 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.59030184 |
82 | metanephric epithelium development (GO:0072207) | 3.56318766 |
83 | angiotensin maturation (GO:0002003) | 3.52697554 |
84 | cellular ketone body metabolic process (GO:0046950) | 3.51378385 |
85 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.51361112 |
86 | alpha-amino acid catabolic process (GO:1901606) | 3.50923725 |
87 | * cellular amino acid catabolic process (GO:0009063) | 3.50824642 |
88 | nephron tubule development (GO:0072080) | 3.48646802 |
89 | * cellular modified amino acid catabolic process (GO:0042219) | 3.47859861 |
90 | regulation of cholesterol homeostasis (GO:2000188) | 3.47247812 |
91 | biotin metabolic process (GO:0006768) | 3.44744720 |
92 | drug metabolic process (GO:0017144) | 3.44014001 |
93 | modulation by symbiont of host immune response (GO:0052553) | 3.40733120 |
94 | positive regulation by symbiont of host defense response (GO:0052509) | 3.40733120 |
95 | modulation by symbiont of host defense response (GO:0052031) | 3.40733120 |
96 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.40733120 |
97 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.40733120 |
98 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.40733120 |
99 | sodium-independent organic anion transport (GO:0043252) | 3.40686219 |
100 | * glutathione biosynthetic process (GO:0006750) | 3.38117072 |
101 | response to growth hormone (GO:0060416) | 3.36610979 |
102 | complement activation, alternative pathway (GO:0006957) | 3.34014221 |
103 | epoxygenase P450 pathway (GO:0019373) | 3.31672544 |
104 | monocarboxylic acid catabolic process (GO:0072329) | 3.31386224 |
105 | negative regulation of digestive system process (GO:0060457) | 3.29475939 |
106 | * carboxylic acid catabolic process (GO:0046395) | 3.27823258 |
107 | * organic acid catabolic process (GO:0016054) | 3.27823258 |
108 | cholesterol efflux (GO:0033344) | 3.27446744 |
109 | aromatic amino acid family metabolic process (GO:0009072) | 3.26882584 |
110 | protein retention in ER lumen (GO:0006621) | 3.26322054 |
111 | kynurenine metabolic process (GO:0070189) | 3.26227012 |
112 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.25642755 |
113 | transcytosis (GO:0045056) | 3.25552948 |
114 | response to peptidoglycan (GO:0032494) | 3.25053067 |
115 | oxaloacetate metabolic process (GO:0006107) | 3.24243581 |
116 | alditol metabolic process (GO:0019400) | 3.23873441 |
117 | tricarboxylic acid cycle (GO:0006099) | 3.23224649 |
118 | NIK/NF-kappaB signaling (GO:0038061) | 3.21929232 |
119 | transepithelial transport (GO:0070633) | 3.21858375 |
120 | succinate metabolic process (GO:0006105) | 3.21047446 |
121 | low-density lipoprotein particle remodeling (GO:0034374) | 3.20585539 |
122 | protein-lipid complex remodeling (GO:0034368) | 3.18709115 |
123 | macromolecular complex remodeling (GO:0034367) | 3.18709115 |
124 | plasma lipoprotein particle remodeling (GO:0034369) | 3.18709115 |
125 | hormone catabolic process (GO:0042447) | 3.18410802 |
126 | high-density lipoprotein particle remodeling (GO:0034375) | 3.17886313 |
127 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.17632992 |
128 | plasma lipoprotein particle organization (GO:0071827) | 3.15969118 |
129 | amino acid transmembrane transport (GO:0003333) | 3.14810204 |
130 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.11846734 |
131 | regulation of protein activation cascade (GO:2000257) | 3.08445957 |
132 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.08431544 |
133 | glycosphingolipid catabolic process (GO:0046479) | 3.06583040 |
134 | 4-hydroxyproline metabolic process (GO:0019471) | 3.06166745 |
135 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.05331946 |
136 | regulation of complement activation (GO:0030449) | 3.05274627 |
137 | negative regulation of sterol transport (GO:0032372) | 3.04846795 |
138 | negative regulation of cholesterol transport (GO:0032375) | 3.04846795 |
139 | detection of molecule of bacterial origin (GO:0032490) | 3.02798487 |
140 | lipoprotein metabolic process (GO:0042157) | 3.01670451 |
141 | regulation of triglyceride catabolic process (GO:0010896) | 2.99252757 |
142 | protein-lipid complex subunit organization (GO:0071825) | 2.99116137 |
143 | acute-phase response (GO:0006953) | 2.95646384 |
144 | glycolipid catabolic process (GO:0019377) | 2.93347639 |
145 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.90942546 |
146 | glucose 6-phosphate metabolic process (GO:0051156) | 2.90228195 |
147 | negative regulation of fibrinolysis (GO:0051918) | 2.89837314 |
148 | urea metabolic process (GO:0019627) | 2.88640730 |
149 | macrophage activation involved in immune response (GO:0002281) | 2.85762890 |
150 | mannose metabolic process (GO:0006013) | 2.84913562 |
151 | urea cycle (GO:0000050) | 2.84609420 |
152 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.82047883 |
153 | protein carboxylation (GO:0018214) | 2.82047883 |
154 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.77899531 |
155 | reverse cholesterol transport (GO:0043691) | 2.77291801 |
156 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.76897805 |
157 | detection of external biotic stimulus (GO:0098581) | 2.74759625 |
158 | nitrogen cycle metabolic process (GO:0071941) | 2.73008320 |
159 | diacylglycerol metabolic process (GO:0046339) | 2.69154117 |
160 | pinocytosis (GO:0006907) | 2.67830620 |
161 | proline biosynthetic process (GO:0006561) | 2.64338152 |
162 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.64253042 |
163 | neutrophil activation involved in immune response (GO:0002283) | 2.63401729 |
164 | detection of other organism (GO:0098543) | 2.62066243 |
165 | detection of bacterium (GO:0016045) | 2.61072832 |
166 | regulation of superoxide anion generation (GO:0032928) | 2.59772600 |
167 | * peptide catabolic process (GO:0043171) | 2.59262523 |
168 | positive regulation of lipid catabolic process (GO:0050996) | 2.53915326 |
169 | regulation of apoptotic cell clearance (GO:2000425) | 2.53883756 |
170 | GDP-mannose metabolic process (GO:0019673) | 2.52214766 |
171 | regulation of bile acid biosynthetic process (GO:0070857) | 2.52154739 |
172 | myeloid dendritic cell differentiation (GO:0043011) | 2.52091586 |
173 | plasma lipoprotein particle clearance (GO:0034381) | 2.51902238 |
174 | complement activation, classical pathway (GO:0006958) | 2.51772487 |
175 | ceramide catabolic process (GO:0046514) | 2.48747984 |
176 | regulation of fibrinolysis (GO:0051917) | 2.47869201 |
177 | immunoglobulin mediated immune response (GO:0016064) | 2.46535595 |
178 | cholesterol homeostasis (GO:0042632) | 2.46377897 |
179 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.46096500 |
180 | * glutathione metabolic process (GO:0006749) | 2.44744952 |
181 | negative regulation of cell killing (GO:0031342) | 2.43763011 |
182 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.43763011 |
183 | alpha-linolenic acid metabolic process (GO:0036109) | 2.43546470 |
184 | sterol homeostasis (GO:0055092) | 2.43399962 |
185 | positive regulation of extracellular matrix organization (GO:1903055) | 2.42761107 |
186 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.42103653 |
187 | detection of biotic stimulus (GO:0009595) | 2.40242534 |
188 | regulation of extracellular matrix organization (GO:1903053) | 2.39648193 |
189 | T-helper 1 type immune response (GO:0042088) | 2.38000474 |
190 | regulation of vitamin metabolic process (GO:0030656) | 2.36976928 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.16254320 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.88503977 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.51209809 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.92639782 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.77444559 |
6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.42543113 |
7 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.41452091 |
8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.18169362 |
9 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.08067126 |
10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.72495881 |
11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.68751609 |
12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.61984619 |
13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.59395959 |
14 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.59032805 |
15 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.40204177 |
16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.28057013 |
17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.27453315 |
18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.19818909 |
19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.19475887 |
20 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.17765688 |
21 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.12165358 |
22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.05807457 |
23 | MYC_22102868_ChIP-Seq_BL_Human | 2.05405880 |
24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.04762546 |
25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.04369924 |
26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.03575120 |
27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03274093 |
28 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.02300492 |
29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.01958099 |
30 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.00584317 |
31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.98324180 |
32 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.90411732 |
33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.89539447 |
34 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.89134656 |
35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.85777647 |
36 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.84755415 |
37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.82964846 |
38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.78934652 |
39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.71980323 |
40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.70667526 |
41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.68223789 |
42 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.66751494 |
43 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66447727 |
44 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.66323735 |
45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66085119 |
46 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.63965991 |
47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.61641577 |
48 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.59185773 |
49 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.59113966 |
50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.58218765 |
51 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.56988494 |
52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.56697003 |
53 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.56539424 |
54 | MAF_26560356_Chip-Seq_TH1_Human | 1.55090934 |
55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54956028 |
56 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.51380321 |
57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46617887 |
58 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.45362807 |
59 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.44542398 |
60 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.42626723 |
61 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.41457982 |
62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38661359 |
63 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.38261014 |
64 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.36106117 |
65 | SPI1_23127762_ChIP-Seq_K562_Human | 1.33320451 |
66 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.32308617 |
67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.31277441 |
68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30360187 |
69 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.29318381 |
70 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.28705206 |
71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28356646 |
72 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.27656524 |
73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.26238201 |
74 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25128558 |
75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23871418 |
76 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.23077841 |
77 | MAF_26560356_Chip-Seq_TH2_Human | 1.22502581 |
78 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21877697 |
79 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.21687067 |
80 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.21411505 |
81 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.21142986 |
82 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20947971 |
83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20411230 |
84 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.19476254 |
85 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.19288992 |
86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.18174074 |
87 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.17725162 |
88 | MYB_26560356_Chip-Seq_TH1_Human | 1.17697007 |
89 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17409697 |
90 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.17161445 |
91 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.17026244 |
92 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16655833 |
93 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.15955811 |
94 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13923424 |
95 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.12702349 |
96 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11947519 |
97 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.11497339 |
98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11360537 |
99 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11113640 |
100 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10329404 |
101 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08741252 |
102 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08144133 |
103 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.06339408 |
104 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06254334 |
105 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05884810 |
106 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05734009 |
107 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.05637640 |
108 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.04843233 |
109 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04528460 |
110 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03794451 |
111 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03698116 |
112 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.03178267 |
113 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02086312 |
114 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01999009 |
115 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01311120 |
116 | MYB_26560356_Chip-Seq_TH2_Human | 1.00920355 |
117 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00384972 |
118 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00346847 |
119 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99147469 |
120 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99084158 |
121 | P68_20966046_ChIP-Seq_HELA_Human | 0.98588356 |
122 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95040160 |
123 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95040160 |
124 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94722931 |
125 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94309843 |
126 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94300223 |
127 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93801452 |
128 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93110846 |
129 | VDR_22108803_ChIP-Seq_LS180_Human | 0.92351124 |
130 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.91192047 |
131 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.90295783 |
132 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88816523 |
133 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.87333021 |
134 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87142889 |
135 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87092326 |
136 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86313922 |
137 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84837964 |
138 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.83338337 |
139 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.83276129 |
140 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.82891807 |
141 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.82647268 |
142 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.81800306 |
143 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.81562883 |
144 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81426933 |
145 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.79735728 |
146 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.79627006 |
147 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.78948265 |
148 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.78749909 |
149 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77568614 |
150 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.77317327 |
151 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.77162078 |
152 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.76634337 |
153 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.76143681 |
154 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.75688664 |
155 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.75102146 |
156 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.74974726 |
157 | RXR_22108803_ChIP-Seq_LS180_Human | 0.72420316 |
158 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.72047720 |
159 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.70510666 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 8.37273504 |
2 | MP0004043_abnormal_pH_regulation | 5.33081743 |
3 | MP0002139_abnormal_hepatobiliary_system | 4.89915232 |
4 | MP0004019_abnormal_vitamin_homeostasis | 4.52343088 |
5 | * MP0005332_abnormal_amino_acid | 4.24349228 |
6 | MP0001666_abnormal_nutrient_absorption | 4.01419033 |
7 | MP0009643_abnormal_urine_homeostasis | 3.62546962 |
8 | MP0005365_abnormal_bile_salt | 3.34797857 |
9 | MP0001765_abnormal_ion_homeostasis | 3.27054660 |
10 | MP0002138_abnormal_hepatobiliary_system | 3.17774548 |
11 | MP0003195_calcinosis | 2.96247632 |
12 | MP0005085_abnormal_gallbladder_physiolo | 2.89908320 |
13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.86830907 |
14 | MP0005377_hearing/vestibular/ear_phenot | 2.86135013 |
15 | MP0003878_abnormal_ear_physiology | 2.86135013 |
16 | MP0003436_decreased_susceptibility_to | 2.81049882 |
17 | MP0005636_abnormal_mineral_homeostasis | 2.76242416 |
18 | MP0001756_abnormal_urination | 2.69354146 |
19 | MP0003252_abnormal_bile_duct | 2.56691256 |
20 | MP0003303_peritoneal_inflammation | 2.56539362 |
21 | MP0002136_abnormal_kidney_physiology | 2.53164463 |
22 | MP0005084_abnormal_gallbladder_morpholo | 2.49368795 |
23 | MP0000685_abnormal_immune_system | 2.13710460 |
24 | MP0009785_altered_susceptibility_to | 2.04257274 |
25 | MP0005058_abnormal_lysosome_morphology | 2.01186078 |
26 | MP0001835_abnormal_antigen_presentation | 2.01053519 |
27 | MP0010155_abnormal_intestine_physiology | 1.96719598 |
28 | MP0004264_abnormal_extraembryonic_tissu | 1.95071394 |
29 | MP0001958_emphysema | 1.93933778 |
30 | MP0005025_abnormal_response_to | 1.88426826 |
31 | MP0002419_abnormal_innate_immunity | 1.83975374 |
32 | MP0003724_increased_susceptibility_to | 1.83289896 |
33 | MP0001790_abnormal_immune_system | 1.80725859 |
34 | MP0005387_immune_system_phenotype | 1.80725859 |
35 | MP0005083_abnormal_biliary_tract | 1.77882074 |
36 | MP0009333_abnormal_splenocyte_physiolog | 1.74359991 |
37 | MP0005220_abnormal_exocrine_pancreas | 1.74152211 |
38 | MP0002148_abnormal_hypersensitivity_rea | 1.74022265 |
39 | MP0000538_abnormal_urinary_bladder | 1.73912493 |
40 | MP0010234_abnormal_vibrissa_follicle | 1.72394894 |
41 | MP0006082_CNS_inflammation | 1.64453329 |
42 | MP0008260_abnormal_autophagy | 1.63645666 |
43 | MP0000858_altered_metastatic_potential | 1.62771584 |
44 | MP0004947_skin_inflammation | 1.61913646 |
45 | MP0005000_abnormal_immune_tolerance | 1.60129135 |
46 | MP0005464_abnormal_platelet_physiology | 1.58388013 |
47 | MP0001800_abnormal_humoral_immune | 1.56856630 |
48 | MP0003806_abnormal_nucleotide_metabolis | 1.54754775 |
49 | MP0005451_abnormal_body_composition | 1.54121175 |
50 | MP0005671_abnormal_response_to | 1.53874313 |
51 | MP0002723_abnormal_immune_serum | 1.48389126 |
52 | MP0003186_abnormal_redox_activity | 1.45749209 |
53 | MP0002452_abnormal_antigen_presenting | 1.43840541 |
54 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.41387090 |
55 | MP0008961_abnormal_basal_metabolism | 1.41240919 |
56 | MP0005319_abnormal_enzyme/_coenzyme | 1.38976646 |
57 | MP0002876_abnormal_thyroid_physiology | 1.32970358 |
58 | MP0002132_abnormal_respiratory_system | 1.30677075 |
59 | MP0004147_increased_porphyrin_level | 1.29959935 |
60 | MP0001819_abnormal_immune_cell | 1.29791804 |
61 | MP0002420_abnormal_adaptive_immunity | 1.29063095 |
62 | MP0003300_gastrointestinal_ulcer | 1.27958496 |
63 | MP0001533_abnormal_skeleton_physiology | 1.27011927 |
64 | MP0004885_abnormal_endolymph | 1.24870229 |
65 | MP0005310_abnormal_salivary_gland | 1.22800393 |
66 | MP0010329_abnormal_lipoprotein_level | 1.17907983 |
67 | MP0002166_altered_tumor_susceptibility | 1.17560086 |
68 | MP0002118_abnormal_lipid_homeostasis | 1.16823663 |
69 | MP0001764_abnormal_homeostasis | 1.15644745 |
70 | MP0003191_abnormal_cellular_cholesterol | 1.12734008 |
71 | MP0002405_respiratory_system_inflammati | 1.11631074 |
72 | MP0003656_abnormal_erythrocyte_physiolo | 1.10955661 |
73 | MP0005076_abnormal_cell_differentiation | 1.09926639 |
74 | MP0003453_abnormal_keratinocyte_physiol | 1.08401657 |
75 | MP0006036_abnormal_mitochondrial_physio | 1.07933941 |
76 | MP0003075_altered_response_to | 1.07428348 |
77 | MP0003638_abnormal_response/metabolism_ | 1.06511705 |
78 | MP0002998_abnormal_bone_remodeling | 1.06169298 |
79 | MP0001664_abnormal_digestion | 1.04929810 |
80 | * MP0000716_abnormal_immune_system | 1.03953867 |
81 | MP0005166_decreased_susceptibility_to | 1.02591727 |
82 | MP0009278_abnormal_bone_marrow | 1.02300850 |
83 | MP0002796_impaired_skin_barrier | 1.01402229 |
84 | MP0003763_abnormal_thymus_physiology | 1.01156509 |
85 | MP0000604_amyloidosis | 1.01014246 |
86 | MP0000230_abnormal_systemic_arterial | 0.97809163 |
87 | MP0002135_abnormal_kidney_morphology | 0.96404328 |
88 | MP0005535_abnormal_body_temperature | 0.93472393 |
89 | MP0002398_abnormal_bone_marrow | 0.91752131 |
90 | MP0005666_abnormal_adipose_tissue | 0.91296368 |
91 | MP0002928_abnormal_bile_duct | 0.88969890 |
92 | MP0003183_abnormal_peptide_metabolism | 0.87646958 |
93 | MP0002933_joint_inflammation | 0.87616700 |
94 | MP0002254_reproductive_system_inflammat | 0.87577811 |
95 | MP0009840_abnormal_foam_cell | 0.86957097 |
96 | * MP0002429_abnormal_blood_cell | 0.86746395 |
97 | MP0005670_abnormal_white_adipose | 0.85900195 |
98 | MP0003959_abnormal_lean_body | 0.85703743 |
99 | MP0002168_other_aberrant_phenotype | 0.85381021 |
100 | MP0003705_abnormal_hypodermis_morpholog | 0.85202254 |
101 | MP0002396_abnormal_hematopoietic_system | 0.83723884 |
102 | MP0001853_heart_inflammation | 0.83041226 |
103 | MP0002896_abnormal_bone_mineralization | 0.81691225 |
104 | MP0000609_abnormal_liver_physiology | 0.81198744 |
105 | MP0002722_abnormal_immune_system | 0.80590578 |
106 | MP0003283_abnormal_digestive_organ | 0.80232003 |
107 | * MP0000689_abnormal_spleen_morphology | 0.79544550 |
108 | MP0000249_abnormal_blood_vessel | 0.79424309 |
109 | MP0003868_abnormal_feces_composition | 0.78960565 |
110 | MP0001849_ear_inflammation | 0.77323920 |
111 | MP0001663_abnormal_digestive_system | 0.76665856 |
112 | MP0004510_myositis | 0.75766829 |
113 | * MP0009642_abnormal_blood_homeostasis | 0.75636494 |
114 | MP0009763_increased_sensitivity_to | 0.74589358 |
115 | MP0002006_tumorigenesis | 0.73207470 |
116 | MP0002098_abnormal_vibrissa_morphology | 0.67243798 |
117 | MP0005501_abnormal_skin_physiology | 0.64416816 |
118 | MP0005381_digestive/alimentary_phenotyp | 0.63682399 |
119 | MP0000598_abnormal_liver_morphology | 0.61332806 |
120 | MP0005408_hypopigmentation | 0.60540048 |
121 | MP0001873_stomach_inflammation | 0.60344671 |
122 | MP0005395_other_phenotype | 0.59962251 |
123 | MP0008469_abnormal_protein_level | 0.57686133 |
124 | MP0003172_abnormal_lysosome_physiology | 0.55119613 |
125 | MP0003866_abnormal_defecation | 0.54898286 |
126 | MP0005165_increased_susceptibility_to | 0.54299062 |
127 | MP0009764_decreased_sensitivity_to | 0.54296438 |
128 | MP0001661_extended_life_span | 0.52902805 |
129 | * MP0002078_abnormal_glucose_homeostasis | 0.50298908 |
130 | MP0003315_abnormal_perineum_morphology | 0.50266573 |
131 | MP0003879_abnormal_hair_cell | 0.48805704 |
132 | * MP0003953_abnormal_hormone_level | 0.47227216 |
133 | MP0001485_abnormal_pinna_reflex | 0.47222121 |
134 | MP0000747_muscle_weakness | 0.46411651 |
135 | MP0005375_adipose_tissue_phenotype | 0.46176585 |
136 | MP0009765_abnormal_xenobiotic_induced | 0.45902286 |
137 | MP0004233_abnormal_muscle_weight | 0.44377205 |
138 | MP0003329_amyloid_beta_deposits | 0.42402912 |
139 | MP0006035_abnormal_mitochondrial_morpho | 0.41026664 |
140 | MP0003646_muscle_fatigue | 0.40262271 |
141 | MP0001944_abnormal_pancreas_morphology | 0.39769417 |
142 | MP0000377_abnormal_hair_follicle | 0.39293774 |
143 | MP0000537_abnormal_urethra_morphology | 0.37240173 |
144 | MP0001845_abnormal_inflammatory_respons | 0.37173597 |
145 | MP0005448_abnormal_energy_balance | 0.36688307 |
146 | MP0002069_abnormal_eating/drinking_beha | 0.35682123 |
147 | MP0010386_abnormal_urinary_bladder | 0.35569022 |
148 | MP0000534_abnormal_ureter_morphology | 0.35446957 |
149 | * MP0003795_abnormal_bone_structure | 0.34738842 |
150 | MP0000490_abnormal_crypts_of | 0.34366132 |
151 | MP0000462_abnormal_digestive_system | 0.33625362 |
152 | MP0000477_abnormal_intestine_morphology | 0.33239791 |
153 | MP0000678_abnormal_parathyroid_gland | 0.32769783 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Gout (HP:0001997) | 6.91775042 |
2 | Increased circulating renin level (HP:0000848) | 6.76427334 |
3 | Metabolic alkalosis (HP:0200114) | 6.53222375 |
4 | Hypokalemic alkalosis (HP:0001949) | 6.34144285 |
5 | Hyperactive renin-angiotensin system (HP:0000841) | 6.18863936 |
6 | Hypomagnesemia (HP:0002917) | 6.15193153 |
7 | Polyuria (HP:0000103) | 5.82739415 |
8 | Abnormal urine output (HP:0012590) | 5.73384870 |
9 | Abnormality of chloride homeostasis (HP:0011422) | 5.72077297 |
10 | Abnormality of renal excretion (HP:0011036) | 5.65547570 |
11 | Proximal tubulopathy (HP:0000114) | 5.47092850 |
12 | Abnormality of magnesium homeostasis (HP:0004921) | 5.36553975 |
13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.22338267 |
14 | Hyperglycinuria (HP:0003108) | 5.21235317 |
15 | Hyperuricemia (HP:0002149) | 5.02228907 |
16 | Increased purine levels (HP:0004368) | 5.02228907 |
17 | Polydipsia (HP:0001959) | 4.68149018 |
18 | Abnormal drinking behavior (HP:0030082) | 4.68149018 |
19 | Abnormality of purine metabolism (HP:0004352) | 4.68004650 |
20 | Deep venous thrombosis (HP:0002625) | 4.41547864 |
21 | Systemic lupus erythematosus (HP:0002725) | 4.36798445 |
22 | Renal salt wasting (HP:0000127) | 4.35305748 |
23 | Abnormality of glycine metabolism (HP:0010895) | 4.26149728 |
24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.26149728 |
25 | Tetany (HP:0001281) | 4.19237010 |
26 | Abnormality of renin-angiotensin system (HP:0000847) | 4.19178233 |
27 | Alkalosis (HP:0001948) | 4.19066444 |
28 | Hyperaldosteronism (HP:0000859) | 4.10367112 |
29 | Generalized aminoaciduria (HP:0002909) | 4.06972697 |
30 | Abnormality of urine glucose concentration (HP:0011016) | 3.86098616 |
31 | Glycosuria (HP:0003076) | 3.86098616 |
32 | Ketoacidosis (HP:0001993) | 3.81160885 |
33 | Hypercalciuria (HP:0002150) | 3.76875386 |
34 | Eczematoid dermatitis (HP:0000976) | 3.67234453 |
35 | Complement deficiency (HP:0004431) | 3.60487704 |
36 | Abnormality of glycolipid metabolism (HP:0010969) | 3.50122879 |
37 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.50122879 |
38 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.50122879 |
39 | Abnormality of proline metabolism (HP:0010907) | 3.47875567 |
40 | Hydroxyprolinuria (HP:0003080) | 3.47875567 |
41 | Abnormality of macrophages (HP:0004311) | 3.47192681 |
42 | Dysostosis multiplex (HP:0000943) | 3.46440852 |
43 | Abnormality of nucleobase metabolism (HP:0010932) | 3.42703409 |
44 | Ketosis (HP:0001946) | 3.39694692 |
45 | Glomerulonephritis (HP:0000099) | 3.36063247 |
46 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.32285830 |
47 | Hypobetalipoproteinemia (HP:0003563) | 3.31015759 |
48 | Hemorrhage of the eye (HP:0011885) | 3.29254149 |
49 | Abnormality of complement system (HP:0005339) | 3.23845194 |
50 | Renal tubular acidosis (HP:0001947) | 3.23659816 |
51 | Hypokalemia (HP:0002900) | 3.23632947 |
52 | Hyperphosphaturia (HP:0003109) | 3.22899707 |
53 | Xanthomatosis (HP:0000991) | 3.22470746 |
54 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.11498497 |
55 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.07178193 |
56 | Malnutrition (HP:0004395) | 3.05107082 |
57 | Abnormal urine phosphate concentration (HP:0012599) | 3.00277553 |
58 | Delayed epiphyseal ossification (HP:0002663) | 2.95662245 |
59 | Nephrolithiasis (HP:0000787) | 2.94852057 |
60 | Vacuolated lymphocytes (HP:0001922) | 2.94311747 |
61 | Flat acetabular roof (HP:0003180) | 2.92969910 |
62 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.92892200 |
63 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.92614055 |
64 | Mucopolysacchariduria (HP:0008155) | 2.92614055 |
65 | Joint hemorrhage (HP:0005261) | 2.90279962 |
66 | Widely patent fontanelles and sutures (HP:0004492) | 2.86143698 |
67 | Hyperglycinemia (HP:0002154) | 2.85159283 |
68 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.83144049 |
69 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.83144049 |
70 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.83144049 |
71 | Recurrent abscess formation (HP:0002722) | 2.81088933 |
72 | Increased cerebral lipofuscin (HP:0011813) | 2.77850169 |
73 | Vascular calcification (HP:0004934) | 2.76345209 |
74 | Purpura (HP:0000979) | 2.73022907 |
75 | Orchitis (HP:0100796) | 2.72644838 |
76 | Dehydration (HP:0001944) | 2.71402196 |
77 | Nephrocalcinosis (HP:0000121) | 2.69758336 |
78 | Prolonged partial thromboplastin time (HP:0003645) | 2.67194707 |
79 | Hypophosphatemia (HP:0002148) | 2.67116834 |
80 | Abnormality of potassium homeostasis (HP:0011042) | 2.66843081 |
81 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.65202683 |
82 | Myositis (HP:0100614) | 2.61893197 |
83 | Delayed CNS myelination (HP:0002188) | 2.61466398 |
84 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.60473541 |
85 | Recurrent bacterial skin infections (HP:0005406) | 2.60285910 |
86 | Hyperammonemia (HP:0001987) | 2.59138766 |
87 | Loss of speech (HP:0002371) | 2.55365453 |
88 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.52586338 |
89 | Dicarboxylic aciduria (HP:0003215) | 2.52586338 |
90 | Metabolic acidosis (HP:0001942) | 2.52067215 |
91 | Metaphyseal cupping (HP:0003021) | 2.49072084 |
92 | Increased serum ferritin (HP:0003281) | 2.48165720 |
93 | Facial shape deformation (HP:0011334) | 2.47761510 |
94 | Potter facies (HP:0002009) | 2.47761510 |
95 | Nephritis (HP:0000123) | 2.47342691 |
96 | Mediastinal lymphadenopathy (HP:0100721) | 2.45897147 |
97 | Cardiovascular calcification (HP:0011915) | 2.44834837 |
98 | Rickets (HP:0002748) | 2.43102397 |
99 | Abnormal tarsal ossification (HP:0008369) | 2.42566410 |
100 | Gingival bleeding (HP:0000225) | 2.41891464 |
101 | Chronic obstructive pulmonary disease (HP:0006510) | 2.41772726 |
102 | Obstructive lung disease (HP:0006536) | 2.41772726 |
103 | Amyloidosis (HP:0011034) | 2.37375461 |
104 | Vomiting (HP:0002013) | 2.33745469 |
105 | Abnormality of the common coagulation pathway (HP:0010990) | 2.32745241 |
106 | Optic neuritis (HP:0100653) | 2.29584507 |
107 | Retrobulbar optic neuritis (HP:0100654) | 2.29584507 |
108 | Myocardial infarction (HP:0001658) | 2.28934489 |
109 | J-shaped sella turcica (HP:0002680) | 2.28622892 |
110 | Confusion (HP:0001289) | 2.28371551 |
111 | Methylmalonic aciduria (HP:0012120) | 2.24841272 |
112 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.17439497 |
113 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.17088365 |
114 | Hyponatremia (HP:0002902) | 2.15956022 |
115 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.15664992 |
116 | Lethargy (HP:0001254) | 2.15278449 |
117 | Abnormality of sodium homeostasis (HP:0010931) | 2.15250234 |
118 | Gingivitis (HP:0000230) | 2.15073939 |
119 | Vasculitis (HP:0002633) | 2.13538721 |
120 | Thin bony cortex (HP:0002753) | 2.12935448 |
121 | Abnormality of the lumbar spine (HP:0100712) | 2.11985076 |
122 | Pustule (HP:0200039) | 2.11479094 |
123 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.10646727 |
124 | Gastrointestinal infarctions (HP:0005244) | 2.08991089 |
125 | Abnormality of renal resorption (HP:0011038) | 2.07610937 |
126 | Ileus (HP:0002595) | 2.03991693 |
127 | Conjugated hyperbilirubinemia (HP:0002908) | 2.03377598 |
128 | Abdominal distention (HP:0003270) | 2.03288689 |
129 | Colitis (HP:0002583) | 2.03033147 |
130 | Prolonged neonatal jaundice (HP:0006579) | 2.02125338 |
131 | Epistaxis (HP:0000421) | 2.01808354 |
132 | Steatorrhea (HP:0002570) | 2.01787442 |
133 | Pathologic fracture (HP:0002756) | 2.01655747 |
134 | Nausea (HP:0002018) | 2.00260101 |
135 | Elevated alkaline phosphatase (HP:0003155) | 1.99997461 |
136 | Menorrhagia (HP:0000132) | 1.98979242 |
137 | Abnormality of iron homeostasis (HP:0011031) | 1.98447297 |
138 | Nuclear cataract (HP:0100018) | 1.97383721 |
139 | Tubulointerstitial fibrosis (HP:0005576) | 1.97221922 |
140 | Meningitis (HP:0001287) | 1.97131666 |
141 | Axonal loss (HP:0003447) | 1.96572537 |
142 | Protuberant abdomen (HP:0001538) | 1.95533017 |
143 | Chronic diarrhea (HP:0002028) | 1.94747497 |
144 | Fat malabsorption (HP:0002630) | 1.94409277 |
145 | Enlarged kidneys (HP:0000105) | 1.94310124 |
146 | Abnormality of the costochondral junction (HP:0000919) | 1.94156873 |
147 | Hypolipoproteinemia (HP:0010981) | 1.93508805 |
148 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.92218226 |
149 | Recurrent fungal infections (HP:0002841) | 1.92043132 |
150 | Renal tubular dysfunction (HP:0000124) | 1.91661798 |
151 | Petechiae (HP:0000967) | 1.89124928 |
152 | Tubular atrophy (HP:0000092) | 1.86830740 |
153 | Cholecystitis (HP:0001082) | 1.86279159 |
154 | Abnormal gallbladder physiology (HP:0012438) | 1.86279159 |
155 | Adrenal overactivity (HP:0002717) | 1.85927879 |
156 | Pulmonary infiltrates (HP:0002113) | 1.84150025 |
157 | Encephalitis (HP:0002383) | 1.82225391 |
158 | Hypotension (HP:0002615) | 1.81855833 |
159 | Sensorimotor neuropathy (HP:0007141) | 1.81149556 |
160 | Joint swelling (HP:0001386) | 1.81099759 |
161 | Gastrointestinal inflammation (HP:0004386) | 1.79986822 |
162 | Focal segmental glomerulosclerosis (HP:0000097) | 1.79802878 |
163 | Wide cranial sutures (HP:0010537) | 1.79615464 |
164 | Glomerulosclerosis (HP:0000096) | 1.79440463 |
165 | Hypercholesterolemia (HP:0003124) | 1.79403451 |
166 | Hepatocellular carcinoma (HP:0001402) | 1.78823374 |
167 | Bone pain (HP:0002653) | 1.78047729 |
168 | Abnormality of vitamin B metabolism (HP:0004340) | 1.76843410 |
169 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.76260544 |
170 | Thrombophlebitis (HP:0004418) | 1.75981816 |
171 | Pancreatitis (HP:0001733) | 1.75592163 |
172 | Recurrent skin infections (HP:0001581) | 1.75328868 |
173 | Thoracic kyphosis (HP:0002942) | 1.75242900 |
174 | Abnormal platelet function (HP:0011869) | 1.74460444 |
175 | Impaired platelet aggregation (HP:0003540) | 1.74460444 |
176 | Irritability (HP:0000737) | 1.74039068 |
177 | Metaphyseal irregularity (HP:0003025) | 1.73479255 |
178 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.72259177 |
179 | Late onset (HP:0003584) | 1.69834038 |
180 | Chondrocalcinosis (HP:0000934) | 1.69758310 |
181 | Bicornuate uterus (HP:0000813) | 1.69376494 |
182 | Lymphangioma (HP:0100764) | 1.68153928 |
183 | Abnormality of serum amino acid levels (HP:0003112) | 1.65544034 |
184 | Megaloblastic anemia (HP:0001889) | 1.65229691 |
Rank | Gene Set | Z-score |
---|---|---|
1 | WNK4 | 8.08046963 |
2 | WNK3 | 6.96562082 |
3 | OXSR1 | 6.48101762 |
4 | BCKDK | 4.69742927 |
5 | STK39 | 4.07541903 |
6 | RIPK4 | 2.58462878 |
7 | STK38L | 2.38958622 |
8 | MST4 | 2.37153146 |
9 | PRPF4B | 2.35796625 |
10 | TYK2 | 2.14285319 |
11 | TBK1 | 2.12221545 |
12 | PDK3 | 2.00023945 |
13 | PDK4 | 2.00023945 |
14 | PDK2 | 1.95036908 |
15 | NEK1 | 1.91792056 |
16 | IRAK4 | 1.91127129 |
17 | SMG1 | 1.89820426 |
18 | ICK | 1.87319269 |
19 | FRK | 1.84874459 |
20 | BLK | 1.80003440 |
21 | MST1R | 1.78951169 |
22 | ERN1 | 1.78885640 |
23 | IKBKE | 1.57703299 |
24 | WNK1 | 1.55202415 |
25 | GRK6 | 1.50194618 |
26 | MAP3K1 | 1.46892385 |
27 | TAOK2 | 1.45866730 |
28 | MATK | 1.42750077 |
29 | SGK494 | 1.41971184 |
30 | SGK223 | 1.41971184 |
31 | CSF1R | 1.36565394 |
32 | FGR | 1.24753126 |
33 | AKT3 | 1.20895645 |
34 | IKBKB | 1.19687384 |
35 | FGFR3 | 1.19442039 |
36 | LRRK2 | 1.17829901 |
37 | STK38 | 1.17592512 |
38 | ACVR1B | 1.16370995 |
39 | TESK2 | 1.14589590 |
40 | MAP2K2 | 1.12709989 |
41 | NME1 | 1.12542852 |
42 | TNK2 | 1.08955238 |
43 | MAP3K13 | 1.08587851 |
44 | CDK12 | 1.02564394 |
45 | CDC42BPA | 0.98942238 |
46 | PTK6 | 0.98577108 |
47 | TRIB3 | 0.97046333 |
48 | JAK3 | 0.91577154 |
49 | FGFR4 | 0.89185923 |
50 | EPHB1 | 0.88433327 |
51 | MAP3K6 | 0.86181004 |
52 | BTK | 0.79410212 |
53 | MAP3K3 | 0.78588712 |
54 | JAK1 | 0.78278451 |
55 | IRAK1 | 0.77315002 |
56 | PRKCI | 0.76926653 |
57 | PIM2 | 0.76101275 |
58 | PINK1 | 0.75062815 |
59 | SYK | 0.75018802 |
60 | PTK2 | 0.72284941 |
61 | MAP3K7 | 0.71230770 |
62 | LYN | 0.71228143 |
63 | FES | 0.71052688 |
64 | IRAK3 | 0.70971291 |
65 | CHUK | 0.69888372 |
66 | SIK3 | 0.69536348 |
67 | HCK | 0.69187424 |
68 | STK10 | 0.69047786 |
69 | LATS1 | 0.68553293 |
70 | SGK3 | 0.68158120 |
71 | GSK3A | 0.67450105 |
72 | STK24 | 0.64139244 |
73 | DYRK1B | 0.62766981 |
74 | MAP3K2 | 0.61315559 |
75 | EPHA2 | 0.61264184 |
76 | LMTK2 | 0.60900320 |
77 | LCK | 0.59109856 |
78 | RIPK1 | 0.58917166 |
79 | PDPK1 | 0.58381992 |
80 | MET | 0.58373257 |
81 | MAP3K5 | 0.57204643 |
82 | NME2 | 0.56045998 |
83 | TESK1 | 0.55681558 |
84 | SGK2 | 0.55354238 |
85 | SIK2 | 0.54772799 |
86 | PAK4 | 0.54199739 |
87 | MAPK11 | 0.53966660 |
88 | HIPK2 | 0.53568366 |
89 | RPS6KL1 | 0.52750957 |
90 | RPS6KC1 | 0.52750957 |
91 | PRKAA1 | 0.51531073 |
92 | MYLK | 0.51076786 |
93 | FER | 0.51015053 |
94 | RET | 0.50561109 |
95 | MAPKAPK2 | 0.49912020 |
96 | INSRR | 0.47975284 |
97 | TTN | 0.46555866 |
98 | EPHA3 | 0.46535972 |
99 | PRKAA2 | 0.44964747 |
100 | YES1 | 0.44675628 |
101 | SCYL2 | 0.44259509 |
102 | ITK | 0.43215215 |
103 | RPS6KA2 | 0.41001683 |
104 | RPS6KA6 | 0.40851840 |
105 | TXK | 0.40758638 |
106 | KSR2 | 0.39334202 |
107 | EIF2AK3 | 0.39269372 |
108 | PDK1 | 0.38576106 |
109 | SGK1 | 0.36342266 |
110 | PKN2 | 0.35362478 |
111 | PRKG2 | 0.33454809 |
112 | TAOK3 | 0.32066393 |
113 | PRKCZ | 0.31018659 |
114 | MAPKAPK3 | 0.30905569 |
115 | BMX | 0.29956094 |
116 | ABL2 | 0.29898391 |
117 | EEF2K | 0.29887924 |
118 | TAOK1 | 0.26811324 |
119 | MAP3K11 | 0.26702196 |
120 | MAP2K1 | 0.26521344 |
121 | PAK3 | 0.25903672 |
122 | TGFBR2 | 0.25763661 |
123 | MAP3K8 | 0.25386427 |
124 | MAP2K6 | 0.22713120 |
125 | PRKCD | 0.19756873 |
126 | IRAK2 | 0.19703221 |
127 | TIE1 | 0.18980671 |
128 | AKT2 | 0.18378786 |
129 | PIK3CG | 0.17339139 |
130 | MTOR | 0.17126211 |
131 | PAK2 | 0.16568627 |
132 | PIM1 | 0.16377515 |
133 | MAP3K10 | 0.16273919 |
134 | STK11 | 0.15650601 |
135 | ZAP70 | 0.15465547 |
136 | PRKD2 | 0.14026071 |
137 | JAK2 | 0.14008238 |
138 | PRKACG | 0.13619181 |
139 | PRKCA | 0.13560461 |
140 | MAPK12 | 0.11530813 |
141 | MAP2K3 | 0.10191226 |
142 | CSK | 0.07170265 |
143 | MAPK15 | 0.06694340 |
144 | SIK1 | 0.05785467 |
145 | TTK | 0.04854279 |
146 | DDR2 | 0.04566931 |
147 | MAP3K14 | 0.04566746 |
148 | CSNK1A1 | 0.04519128 |
149 | MAP4K1 | 0.03343791 |
150 | INSR | 0.03305000 |
151 | PRKACA | 0.03280550 |
152 | NTRK1 | 0.03150629 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.37844749 |
2 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.18038324 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.15248266 |
4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.08577927 |
5 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.08486790 |
6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.98465187 |
7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.93998101 |
8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.92261219 |
9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.88343554 |
10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.58387998 |
11 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.48345602 |
12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.47602786 |
13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.45859155 |
14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.45236762 |
15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.30403946 |
16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.21975474 |
17 | Peroxisome_Homo sapiens_hsa04146 | 2.21882624 |
18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.19718521 |
19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.15321149 |
20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.14978015 |
21 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.05210407 |
22 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.92869214 |
23 | Mineral absorption_Homo sapiens_hsa04978 | 1.90090369 |
24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.86599591 |
25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83912939 |
26 | Bile secretion_Homo sapiens_hsa04976 | 1.76834414 |
27 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.68232583 |
28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.65303426 |
29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.61181175 |
30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.59543198 |
31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.58359453 |
32 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.55689397 |
33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.55354376 |
34 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.54603415 |
35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.44405815 |
36 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.44395005 |
37 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.43998468 |
38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.39327401 |
39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37308595 |
40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.34240993 |
41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.34160922 |
42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.33789100 |
43 | * Glutathione metabolism_Homo sapiens_hsa00480 | 1.32230738 |
44 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.31889323 |
45 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.31755002 |
46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.27555935 |
47 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.26906335 |
48 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.23166625 |
49 | Histidine metabolism_Homo sapiens_hsa00340 | 1.20129716 |
50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.20111968 |
51 | Allograft rejection_Homo sapiens_hsa05330 | 1.19665231 |
52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.18790530 |
53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16163105 |
54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.13664281 |
55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.13625384 |
56 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.13226260 |
57 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12898562 |
58 | Pertussis_Homo sapiens_hsa05133 | 1.12360509 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 1.11744337 |
60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.11233361 |
61 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.10233259 |
62 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09073384 |
63 | Tuberculosis_Homo sapiens_hsa05152 | 1.07550876 |
64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.05304060 |
65 | Influenza A_Homo sapiens_hsa05164 | 1.00317465 |
66 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.98266154 |
67 | Asthma_Homo sapiens_hsa05310 | 0.90012145 |
68 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.89949815 |
69 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.88085114 |
70 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86795385 |
71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.84214294 |
72 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.80990511 |
73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.79255447 |
74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.79181857 |
75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78071425 |
76 | Prion diseases_Homo sapiens_hsa05020 | 0.77716307 |
77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77684589 |
78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76979702 |
79 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76810351 |
80 | Legionellosis_Homo sapiens_hsa05134 | 0.76715097 |
81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76401770 |
82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74718662 |
83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73630477 |
84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72237294 |
85 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69737489 |
86 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.68143929 |
87 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67616438 |
88 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.65390189 |
89 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63367793 |
90 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.62002498 |
91 | Lysosome_Homo sapiens_hsa04142 | 0.61723415 |
92 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60536552 |
93 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.59558358 |
94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58001619 |
95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57591002 |
96 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55682738 |
97 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.55317930 |
98 | Bladder cancer_Homo sapiens_hsa05219 | 0.53755480 |
99 | Malaria_Homo sapiens_hsa05144 | 0.52744518 |
100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.52673016 |
101 | Measles_Homo sapiens_hsa05162 | 0.52259724 |
102 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.52165167 |
103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.51821435 |
104 | Apoptosis_Homo sapiens_hsa04210 | 0.51487914 |
105 | Salmonella infection_Homo sapiens_hsa05132 | 0.51239055 |
106 | Hepatitis B_Homo sapiens_hsa05161 | 0.49171583 |
107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48788710 |
108 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46561916 |
109 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46249821 |
110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.45826462 |
111 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.44578910 |
112 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.44460831 |
113 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42125061 |
114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40127767 |
115 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38805602 |
116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37377957 |
117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.37343422 |
118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.35900732 |
119 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.34776893 |
120 | Retinol metabolism_Homo sapiens_hsa00830 | 0.34424274 |
121 | Sulfur relay system_Homo sapiens_hsa04122 | 0.33802844 |
122 | Parkinsons disease_Homo sapiens_hsa05012 | 0.31777012 |
123 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31600685 |
124 | ABC transporters_Homo sapiens_hsa02010 | 0.25894862 |
125 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.23901288 |
126 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.21602416 |
127 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.17652945 |
128 | * Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.16697024 |
129 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.15147853 |
130 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.14421518 |
131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.13944131 |
132 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.13062223 |
133 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.09272251 |
134 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.08329186 |
135 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08297177 |
136 | Alzheimers disease_Homo sapiens_hsa05010 | 0.07856411 |
137 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.07825609 |
138 | Insulin resistance_Homo sapiens_hsa04931 | 0.07354649 |
139 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.07159333 |
140 | Tight junction_Homo sapiens_hsa04530 | 0.05578228 |
141 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.02437215 |
142 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00917439 |
143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.00392351 |
144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0041139 |
145 | Hepatitis C_Homo sapiens_hsa05160 | -0.0040468 |